Theodore J Price Selected Research

Anisomycin

1/2021	De novo protein synthesis is necessary for priming in preclinical models of migraine.
4/2015	Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodore J Price Research Topics

Disease

65	Pain (Aches) 01/2022 - 01/2005
33	Hypersensitivity (Allergy) 01/2022 - 11/2010
26	Chronic Pain 01/2022 - 11/2010
24	Hyperalgesia 07/2021 - 01/2005
18	Neuralgia (Stump Neuralgia) 01/2022 - 02/2010
15	Inflammation (Inflammations) 06/2022 - 11/2003
10	Migraine Disorders (Migraine) 01/2022 - 01/2012
9	Peripheral Nerve Injuries 01/2020 - 01/2005
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2014
6	Neoplasms (Cancer) 01/2021 - 07/2013
6	Postoperative Pain 10/2019 - 01/2013
4	Acute Pain 12/2020 - 02/2010
3	Asthma (Bronchial Asthma) 06/2022 - 01/2022
3	Respiratory Hypersensitivity 06/2022 - 01/2022
2	COVID-19 01/2021 - 10/2020
2	Cognitive Dysfunction 01/2021 - 01/2020
2	Neurogenic Inflammation 10/2020 - 11/2003
2	Virus Diseases (Viral Diseases) 10/2020 - 01/2020
2	Ganglion Cysts (Ganglion) 01/2020 - 09/2006
2	Surgical Wound 10/2019 - 01/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2009
11	Interleukin-6 (Interleukin 6)IBA 07/2021 - 11/2010
11	Phosphotransferases (Kinase)IBA 01/2021 - 01/2012
11	Metformin (Glucophage)FDA LinkGeneric 10/2019 - 09/2011
9	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 03/2013
8	Pharmaceutical PreparationsIBA 01/2020 - 06/2012
6	Messenger RNA (mRNA)IBA 01/2022 - 09/2006
6	Peptides (Polypeptides)IBA 01/2021 - 06/2012
6	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
6	Eukaryotic Initiation Factor-4EIBA 01/2021 - 01/2017
6	Adenosine Monophosphate (AMP)IBA 07/2016 - 09/2011
6	Protein Kinases (Protein Kinase)IBA 07/2016 - 09/2011
5	Calcitonin Gene-Related PeptideIBA 01/2022 - 11/2003
5	Sirolimus (Rapamycin)FDA Link 01/2021 - 12/2007
5	Mitogen-Activated Protein KinasesIBA 01/2021 - 07/2016
5	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2012
5	Analgesics (Analgesic Drugs)IBA 01/2018 - 11/2010
4	Peptide Hydrolases (Proteases)FDA Link 06/2022 - 09/2015
4	CarrageenanIBA 01/2022 - 04/2015
4	LigandsIBA 01/2022 - 01/2017
4	ProlactinIBA 01/2022 - 10/2019
4	Formaldehyde (Formol)FDA Link 01/2022 - 12/2007
4	CytokinesIBA 01/2021 - 11/2010
4	AMP-Activated Protein KinasesIBA 10/2019 - 09/2011
4	Opioid Analgesics (Opioids)IBA 02/2019 - 12/2011
4	gamma-Aminobutyric Acid (GABA)IBA 04/2014 - 01/2005
3	RNA Cap-Binding Proteins (Cap Binding Protein)IBA 01/2021 - 01/2017
3	Protein Synthesis InhibitorsIBA 01/2021 - 07/2014
3	Peptide Initiation Factors (Initiation Factor)IBA 12/2020 - 11/2010
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020 - 09/2015
3	PAR-2 ReceptorIBA 01/2020 - 05/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 08/2019 - 01/2014
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 07/2013
3	Dopamine (Intropin)FDA LinkGeneric 10/2018 - 06/2007
3	Nerve Growth Factor (NGF)IBA 01/2017 - 11/2010
3	Eukaryotic Initiation Factor-4F (EIF4F)IBA 05/2015 - 11/2010
3	K Cl- CotransportersIBA 04/2014 - 02/2010
2	AllergensIBA 06/2022 - 01/2022
2	PeptidomimeticsIBA 01/2022 - 05/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2005
2	EnzymesIBA 01/2022 - 04/2014
2	NAD (NADH)IBA 01/2022 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021 - 07/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 07/2017
2	AnisomycinIBA 01/2021 - 04/2015
2	PlasticsIBA 01/2021 - 01/2018
2	HMGB1 Protein (HMG1)IBA 01/2021 - 01/2021
2	DisulfidesIBA 01/2021 - 01/2021
2	p-Methoxy-N-methylphenethylamineIBA 01/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2014
2	Proteinase-Activated ReceptorsIBA 01/2020 - 05/2015
2	tomivosertibIBA 01/2020 - 01/2019
2	MK-8722IBA 10/2019 - 08/2019
2	narciclasineIBA 10/2019 - 08/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 07/2013
2	Gabapentin (Neurontin)FDA LinkGeneric 04/2018 - 01/2017
2	ResveratrolIBA 01/2017 - 01/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 01/2012
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016 - 05/2011
2	U 0126 (UO 126)IBA 05/2015 - 01/2012
2	Acetazolamide (Diamox)FDA LinkGeneric 04/2014 - 02/2010
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2014 - 02/2010
2	TOR Serine-Threonine KinasesIBA 07/2013 - 12/2007
2	Midazolam (Versed)FDA LinkGeneric 06/2012 - 02/2010
2	BenzodiazepinesIBA 06/2012 - 02/2010
2	GABA-A Receptors (GABA(A) Receptor)IBA 06/2012 - 04/2009
2	metabotropic glutamate receptor type 1IBA 05/2011 - 12/2007
2	3,4-dihydroxyphenylglycolIBA 05/2011 - 12/2007
2	Capsaicin (Zostrix)FDA Link 02/2010 - 06/2007
2	CationsIBA 04/2009 - 01/2005
2	ChloridesIBA 04/2009 - 01/2005
1	ArrestinIBA 06/2022
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2022

Therapy/Procedure

28	Therapeutics 06/2022 - 04/2009
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
4	Spinal Injections 04/2016 - 12/2007
3	Analgesia 01/2022 - 04/2014
3	Ligation 04/2016 - 12/2011